Mumbai: After months of sluggish growth in the aftermath of the GST’s implementation, the organised retail pharma market showed the first signs of a revival in October. The market registered a decent growth of 6.5%, with sales of Rs 10,376 crore in October, buoyed by strong growth in dermatology and anti-diabetic drugs, and a turnaround in gastro-intestinal medicines and anti-infectives.
Earlier, the market had posted a degrowth of 2.4% in July, with a weak growth subsequently in August (2.4%) and September (2.8%).
During October, volumes grew 5.6% but the price component dragged the market (at -1.7%), according to figures from pharmaceutical research firm AIOCD Awacs. The April-October period growth figure was only 4.1%, it said, adding this reflected the impact of the run-up to the GST and its eventual implementation.
From a therapy perspective, 18 showed a positive
read more »